Patients with 3‐Vessel Coronary Artery Disease and Impaired Ventricular Function Undergoing PCI with Impella 2.5 Hemodynamic Support Have Improved 90‐Day Outcomes Compared to Intra‐Aortic Balloon Pump: A Sub‐Study of The PROTECT II Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1540-8183|28|1|32-40

ISSN： 0896-4327

Source： JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol.28, Iss.1, 2015-02, pp. : 32-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic Application of an Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

By  

Cardiology, Vol. 131, Iss. 2, 2015-04 ,pp. : 109-115

Karger

Access to resources Recommend Favorite

First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices

By  

Cardiology, Vol. 138, Iss. 1, 2017-05 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Intra‐aortic balloon pump insertion through the right subclavian artery in a patient of anterior wall myocardial infarction with ventricular septal rupture and severe peripheral artery obstruction disease

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : E99-E102

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effects of Intra-Aortic Balloon Pump Support on Macrocirculation and Tissue Microcirculation in Patients with Cardiogenic Shock

By  

Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Cardiopulmonary bypass and intra‐aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 316-322

John Wiley & Sons Inc

Access to resources Recommend Favorite